The influence on skin penetration by dithranol formulated in phospholipid solutions and phospholipid liposomes

W. Gehring, M. Ghyczy-, J. Gareiss, M. Gloor

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Dithranol 0.5% was applied occlusively for 10 min to the healthy skin of 10 volunteers in three anhydrous, nonliposomal phospholipid formulations and in one phospholipid liposome base. The development of dithranol erythema was monitored chromametrically and by laser Doppler flowmetry after 24, 48, and 72 h. A potentiation of the dithranol erythema was only detected for the liposomal formulation. The penetration-promoting effect for dithranol was attributed to the liposomal structure and not to the phospholipid content.

Original languageEnglish
Pages (from-to)140-142
Number of pages3
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Volume41
Issue number2
Publication statusPublished - 1995

Fingerprint

Anthralin
Liposomes
Phospholipids
Skin
Erythema
Laser-Doppler Flowmetry
Volunteers

Keywords

  • dithranol
  • irritation
  • non-liposomal phospholipids
  • penetration promotion
  • phospholipid liposomes

ASJC Scopus subject areas

  • Biotechnology
  • Pharmaceutical Science

Cite this

The influence on skin penetration by dithranol formulated in phospholipid solutions and phospholipid liposomes. / Gehring, W.; Ghyczy-, M.; Gareiss, J.; Gloor, M.

In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 41, No. 2, 1995, p. 140-142.

Research output: Contribution to journalArticle

@article{57b200ff14f544b0949f96af02d00dab,
title = "The influence on skin penetration by dithranol formulated in phospholipid solutions and phospholipid liposomes",
abstract = "Dithranol 0.5{\%} was applied occlusively for 10 min to the healthy skin of 10 volunteers in three anhydrous, nonliposomal phospholipid formulations and in one phospholipid liposome base. The development of dithranol erythema was monitored chromametrically and by laser Doppler flowmetry after 24, 48, and 72 h. A potentiation of the dithranol erythema was only detected for the liposomal formulation. The penetration-promoting effect for dithranol was attributed to the liposomal structure and not to the phospholipid content.",
keywords = "dithranol, irritation, non-liposomal phospholipids, penetration promotion, phospholipid liposomes",
author = "W. Gehring and M. Ghyczy- and J. Gareiss and M. Gloor",
year = "1995",
language = "English",
volume = "41",
pages = "140--142",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - The influence on skin penetration by dithranol formulated in phospholipid solutions and phospholipid liposomes

AU - Gehring, W.

AU - Ghyczy-, M.

AU - Gareiss, J.

AU - Gloor, M.

PY - 1995

Y1 - 1995

N2 - Dithranol 0.5% was applied occlusively for 10 min to the healthy skin of 10 volunteers in three anhydrous, nonliposomal phospholipid formulations and in one phospholipid liposome base. The development of dithranol erythema was monitored chromametrically and by laser Doppler flowmetry after 24, 48, and 72 h. A potentiation of the dithranol erythema was only detected for the liposomal formulation. The penetration-promoting effect for dithranol was attributed to the liposomal structure and not to the phospholipid content.

AB - Dithranol 0.5% was applied occlusively for 10 min to the healthy skin of 10 volunteers in three anhydrous, nonliposomal phospholipid formulations and in one phospholipid liposome base. The development of dithranol erythema was monitored chromametrically and by laser Doppler flowmetry after 24, 48, and 72 h. A potentiation of the dithranol erythema was only detected for the liposomal formulation. The penetration-promoting effect for dithranol was attributed to the liposomal structure and not to the phospholipid content.

KW - dithranol

KW - irritation

KW - non-liposomal phospholipids

KW - penetration promotion

KW - phospholipid liposomes

UR - http://www.scopus.com/inward/record.url?scp=0029041477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029041477&partnerID=8YFLogxK

M3 - Article

VL - 41

SP - 140

EP - 142

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

IS - 2

ER -